Paul K. Pattengale

7.9k total citations · 5 hit papers
57 papers, 5.8k citations indexed

About

Paul K. Pattengale is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Paul K. Pattengale has authored 57 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 13 papers in Oncology and 13 papers in Genetics. Recurrent topics in Paul K. Pattengale's work include Virus-based gene therapy research (11 papers), Immune Cell Function and Interaction (10 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Paul K. Pattengale is often cited by papers focused on Virus-based gene therapy research (11 papers), Immune Cell Function and Interaction (10 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Paul K. Pattengale collaborates with scholars based in United States, Sweden and China. Paul K. Pattengale's co-authors include Philip Leder, Timothy A. Stewart, Eric Sinn, William J. Muller, Robert I. Tepper, Nora Heisterkamp, John Groffen, Isidore Tepler, Guido Jenster and Aya Leder and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Paul K. Pattengale

57 papers receiving 5.5k citations

Hit Papers

Single-step induction of mammary adenocarcinoma in transg... 1984 2026 1998 2012 1988 1984 1989 1987 1990 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul K. Pattengale United States 24 2.5k 2.1k 1.5k 1.3k 827 57 5.8k
E. Solomon United Kingdom 40 3.4k 1.4× 1.4k 0.6× 829 0.6× 1.5k 1.2× 858 1.0× 110 6.3k
HP Koeffler United States 44 3.1k 1.2× 1.8k 0.8× 1.6k 1.1× 825 0.6× 2.0k 2.5× 90 6.5k
Selina Chen‐Kiang United States 47 3.4k 1.4× 2.6k 1.2× 1.9k 1.3× 588 0.5× 1.1k 1.3× 147 6.6k
Edward A. Fox United States 33 4.8k 1.9× 1.7k 0.8× 632 0.4× 1.8k 1.4× 1.0k 1.2× 53 7.4k
Ivo P. Touw Netherlands 42 1.9k 0.8× 2.0k 0.9× 2.6k 1.7× 1.6k 1.3× 1.7k 2.1× 145 5.7k
James A. Zwiebel United States 44 4.7k 1.9× 2.5k 1.2× 484 0.3× 1.7k 1.4× 801 1.0× 140 7.3k
Richard A. Ashmun United States 30 5.9k 2.4× 4.5k 2.1× 1.0k 0.7× 811 0.6× 598 0.7× 53 8.4k
John P. McKearn United States 23 1.9k 0.8× 939 0.4× 1.4k 1.0× 281 0.2× 514 0.6× 56 3.7k
Tucker W. LeBien United States 45 2.1k 0.8× 1.4k 0.6× 3.5k 2.4× 519 0.4× 2.1k 2.5× 139 7.6k
Arthur L. Shaffer United States 36 3.2k 1.3× 1.9k 0.9× 4.0k 2.7× 381 0.3× 964 1.2× 55 7.9k

Countries citing papers authored by Paul K. Pattengale

Since Specialization
Citations

This map shows the geographic impact of Paul K. Pattengale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul K. Pattengale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul K. Pattengale more than expected).

Fields of papers citing papers by Paul K. Pattengale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul K. Pattengale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul K. Pattengale. The network helps show where Paul K. Pattengale may publish in the future.

Co-authorship network of co-authors of Paul K. Pattengale

This figure shows the co-authorship network connecting the top 25 collaborators of Paul K. Pattengale. A scholar is included among the top collaborators of Paul K. Pattengale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul K. Pattengale. Paul K. Pattengale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Tovar, Jason P., Paul K. Pattengale, Larry Wang, et al.. (2012). Subcutaneous Panniculitis-Like T-Cell Lymphoma in Two Pediatric Patients: An HIV-Positive Adolescent and a 4-Month-Old Infant. Fetal and Pediatric Pathology. 32(3). 175–183. 7 indexed citations
4.
Hemmeryckx, Bianca, Anja Reichert, Vesa Kaartinen, et al.. (2002). BCR/ABL P190 transgenic mice develop leukemia in the absence of Crkl. Oncogene. 21(20). 3225–3231. 23 indexed citations
5.
Brown, Michael P., David J. Topham, Mark Y. Sangster, et al.. (1998). Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice. Nature Medicine. 4(11). 1253–1260. 116 indexed citations
6.
Deng, Ping, Yinglin Wang, Yoichi Haga, & Paul K. Pattengale. (1998). Multiple Factors Determine the Selection of the Ectodomain Cleavage Site of Human Cell Surface Macrophage Colony-Stimulating Factor. Biochemistry. 37(51). 17898–17904. 9 indexed citations
7.
Kuefer, Martin U., A. Thomas Look, Karen Pulford, et al.. (1997). Retrovirus-Mediated Gene Transfer of NPM-ALK Causes Lymphoid Malignancy in Mice. Blood. 90(8). 2901–2910. 215 indexed citations
8.
9.
Feuer, Gerold, William T. Lee, Paul K. Pattengale, & Hung Fan. (1993). Specificity of Disease Induced by M-MuLV Chimeric Retroviruses Containing v-myc or v-src Is Not Determined by the LTR. Virology. 195(1). 286–291. 2 indexed citations
10.
Heisterkamp, Nora, Guido Jenster, Dimitris Kioussis, Paul K. Pattengale, & J Groffen. (1991). Humanbcr-abl gene has a lethal effect on embryogenesis. Transgenic Research. 1(1). 45–53. 52 indexed citations
11.
Tepper, Robert I., Paul K. Pattengale, & Philip Leder. (1989). Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell. 57(3). 503–512. 665 indexed citations breakdown →
12.
Chang, Weng‐Cheng, Yoshiaki Fujimiya, Nancy Casteel, & Paul K. Pattengale. (1989). Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. III. Defective interleukin‐2 production by t‐helper and natural killer cells. International Journal of Cancer. 43(4). 591–597. 19 indexed citations
13.
Muller, William J., et al.. (1988). Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell. 54(1). 105–115. 944 indexed citations breakdown →
14.
Nussenzweig, Michel C., Emmett V. Schmidt, Albert C. Shaw, et al.. (1988). A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice. Nature. 336(6198). 446–450. 61 indexed citations
15.
Feuerman, Miriam H., William T. Lee, Paul K. Pattengale, & Hung Fan. (1988). Comparison of three recombinant murine leukemia viruses carrying the v‐src oncogene of avian sarcoma virus: Differences in in vitro transformation and in vivo pathogenicity. Molecular Carcinogenesis. 1(1). 57–66. 3 indexed citations
17.
18.
Stewart, Timothy A., Paul K. Pattengale, & Philip Leder. (1984). Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell. 38(3). 627–637. 697 indexed citations breakdown →
19.
Roy‐Burman, Pradip, Paul K. Pattengale, & Russell P. Sherwìn. (1982). Effect of low levels of nitrogen dioxide inhalation on endogenous retrovirus gene expression. Experimental and Molecular Pathology. 36(2). 144–155. 11 indexed citations
20.
Pattengale, Paul K., Barbara Schneider, Jōhn W. Parker, et al.. (1976). Surface Immunoglobulin on Leukemic, Leukemoid, and Normal Granulocytes 2. JNCI Journal of the National Cancer Institute. 56(6). 1269–1270. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026